BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28112281)

  • 1. A measure of productivity and innovation in the pharmaceutical industry 2011-2015.
    Harrison R
    Drugs Today (Barc); 2016 Nov; 52(11):627-633. PubMed ID: 28112281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mergers and innovation in the pharmaceutical industry.
    Comanor WS; Scherer FM
    J Health Econ; 2013 Jan; 32(1):106-13. PubMed ID: 23220457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2014 Jul; 57(13):5525-53. PubMed ID: 24428137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 1. Criticisms faced by the pharmaceutical industry.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2013 Jul; 56(14):5659-72. PubMed ID: 23557017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open innovation in early drug discovery: roadmaps and roadblocks.
    Reichman M; Simpson PB
    Drug Discov Today; 2016 May; 21(5):779-88. PubMed ID: 26743597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery in pharmaceutical industry: productivity challenges and trends.
    Khanna I
    Drug Discov Today; 2012 Oct; 17(19-20):1088-102. PubMed ID: 22627006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accessing external innovation in drug discovery and development.
    Tufféry P
    Expert Opin Drug Discov; 2015 Jun; 10(6):579-89. PubMed ID: 25910932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift.
    Sams-Dodd F
    Drug Discov Today; 2013 Mar; 18(5-6):211-7. PubMed ID: 23131208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional technology gap and innovation efficiency trap in Chinese pharmaceutical manufacturing industry.
    Lai H; Shi H; Zhou Y
    PLoS One; 2020; 15(5):e0233093. PubMed ID: 32433705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racing to define pharmaceutical R&D external innovation models.
    Wang L; Plump A; Ringel M
    Drug Discov Today; 2015 Mar; 20(3):361-70. PubMed ID: 25448753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational effectiveness: a key to R&D productivity.
    Tollman P; Panier V; Dosik D; Biondi P; Cuss F
    Nat Rev Drug Discov; 2016 Jul; 15(7):441-2. PubMed ID: 27312725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring the effectiveness and impact of an open innovation platform.
    Carroll GP; Srivastava S; Volini AS; Piñeiro-Núñez MM; Vetman T
    Drug Discov Today; 2017 May; 22(5):776-785. PubMed ID: 28137644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The productivity crisis in pharmaceutical R&D.
    Pammolli F; Magazzini L; Riccaboni M
    Nat Rev Drug Discov; 2011 Jun; 10(6):428-38. PubMed ID: 21629293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On strategic choices faced by large pharmaceutical laboratories and their effect on innovation risk under fuzzy conditions.
    Puente J; Gascon F; Ponte B; de la Fuente D
    Artif Intell Med; 2019 Sep; 100():101703. PubMed ID: 31607342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on the influence of technological innovation on carbon productivity and countermeasures in China.
    Han B
    Environ Sci Pollut Res Int; 2021 Apr; 28(13):16880-16894. PubMed ID: 33392990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Productive university, industry, and government relationships in preclinical drug discovery and development: considerations toward a synergistic lingua franca.
    Janero DR
    Expert Opin Drug Discov; 2012 Jun; 7(6):449-56. PubMed ID: 22540843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American export control, technology spillover and innovation of Chinese pharmaceutical Industry.
    Hui J
    Pak J Pharm Sci; 2017 May; 30(3(Special)):1151-1155. PubMed ID: 28671099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open innovation platforms to boost pharmaceutical collaborations: evaluating external compounds for desired biological activity.
    Nilsson N; Felding J
    Future Med Chem; 2015; 7(14):1853-9. PubMed ID: 26393392
    [No Abstract]   [Full Text] [Related]  

  • 19. How to improve R&D productivity: the pharmaceutical industry's grand challenge.
    Paul SM; Mytelka DS; Dunwiddie CT; Persinger CC; Munos BH; Lindborg SR; Schacht AL
    Nat Rev Drug Discov; 2010 Mar; 9(3):203-14. PubMed ID: 20168317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Open innovation for pharmaceutical industries].
    Matsumoto Y; Sakata T
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):199-204. PubMed ID: 23575425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.